In cHL, RSC is strongly and homogeneously CD30 positive, whereas B cell markers, when present, demonstrate a variable pattern of expression and are commonly weaker than CD30 [5,7]. This evidence concerns the gene TNFRSF8 and classic Hodgkin lymphoma.